TRUSCREEN GROUP LIMITED (TRU)

---

AI Coverage Rating: Moderate

ASX AI Signals has generated 1 signal(s) for TRU during the last 90 days, indicating Moderate trading activity

Latest TRU Signals
28/05/2026	BUY
TRU Share Price
Current Price	$0.012
52 Week High	$0.019
52 Week Low:	$0.012
Trading at (% of 52 Week High)	63.16%

Business Overview

Truscreen Group Limited (ASX: TRU) develops and commercializes medical imaging technology for the early detection of cervical cancer. Its flagship product, TruScreen, is a diagnostic device designed to provide rapid, accurate cervical screening results. The company focuses on improving women's health through innovative, non-invasive screening solutions.

ASX Sector Overview

Sector:   Health Care Equipment & Services

The Health Care Equipment & Services sector on the ASX includes companies that produce medical devices, equipment, and supplies, as well as those providing healthcare-related services. This sector covers a wide range of products such as surgical instruments, diagnostic machines, and health monitoring devices. It also includes businesses involved in healthcare management, medical laboratories, and support services. These companies play a key role in supporting hospitals, clinics, and other healthcare providers to improve patient care. The sector is influenced by factors like technological advances, regulatory changes, and demand for healthcare services.

Latest AI Recommendation

The BUY signal for TRUSCREEN GROUP LIMITED at a low price point suggests potential upside; however, limited available data and the low stock price indicate higher volatility and risk, warranting a cautious approach.

Latest  TRUSCREEN GROUP LIMITED(TRU)   News